{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:23:35Z","timestamp":1787743415643,"version":"build-2784847793"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","funder":[{"name":"Ohio State University"},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["HL161514"],"award-info":[{"award-number":["HL161514"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To examine the association between elevated blood pressure (BP) in the early third trimester and cardiometabolic health 10\u201314 years after delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This is a secondary analysis from the prospective HAPO FUS (Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study). Blood pressure in the early third trimester was categorized per American College of Cardiology\/American Heart Association thresholds for: normal BP below 120\/80 mm Hg (reference), elevated BP 120\u2013129\/below 80 mm Hg, stage 1 hypertension 130\u2013139\/80\u201389 mm Hg, and stage 2 hypertension 140\/90 mm Hg or higher. Cardiometabolic outcomes assessed 10\u201314 years after the index pregnancy were type 2 diabetes mellitus and measures of dyslipidemia, including low-density lipoprotein (LDL) cholesterol 130 mg\/dL or higher, total cholesterol 200 mg\/dL or higher, high-density lipoprotein (HDL) cholesterol 40 mg\/dL or lower, and triglycerides 200 mg\/dL or higher. Adjusted analysis was performed with the following covariates: study field center, follow-up duration, age, body mass index (BMI), height, family history of hypertension and diabetes, smoking and alcohol use, parity, and oral glucose tolerance test glucose z score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Among 4,692 pregnant individuals at a median gestational age of 27.9 weeks (interquartile range 26.6\u201328.9 weeks), 8.5% (n=399) had elevated BP, 14.9% (n=701) had stage 1 hypertension, and 6.4% (n=302) had stage 2 hypertension. At a median follow-up of 11.6 years, among individuals with elevated BP, there was a higher frequency of diabetes (elevated BP: adjusted relative risk [aRR] 1.88, 95% CI, 1.06\u20133.35; stage 1 hypertension: aRR 2.58, 95% CI, 1.62\u20134.10; stage 2 hypertension: aRR 2.83, 95% CI, 1.65\u20134.95) compared with those with normal BP. Among individuals with elevated BP, there was a higher frequency of elevated LDL cholesterol (elevated BP: aRR 1.27, 95% CI, 1.03\u20131.57; stage 1 hypertension: aRR 1.22, 95% CI, 1.02\u20131.45, and stage 2 hypertension: aRR 1.38, 95% CI, 1.10\u20131.74), elevated total cholesterol (elevated BP: aRR 1.27, 95% CI, 1.07\u20131.52; stage 1 hypertension: aRR 1.16, 95% CI, 1.00\u20131.35; stage 2 hypertension: aRR 1.41 95% CI, 1.16\u20131.71), and elevated triglycerides (elevated BP: aRR 2.24, 95% CI, 1.42\u20133.53; stage 1 hypertension: aRR 2.15, 95% CI, 1.46\u20133.17; stage 2 hypertension: aRR 3.24, 95% CI, 2.05\u20135.11) but not of low HDL cholesterol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The frequency of adverse cardiometabolic outcomes at 10\u201314 years after delivery was progressively higher among pregnant individuals with BP greater than 120\/80 in the early third trimester.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005674","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T17:01:29Z","timestamp":1721149289000},"page":"395-402","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Elevated Blood Pressure in Pregnancy and Long-Term Cardiometabolic Health Outcomes"],"prefix":"10.1097","volume":"144","author":[{"given":"Christine","family":"Field","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Grobman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Scholtens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilay S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik K.","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"R1-20260826","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"Chronic hypertension in pregnancy. ACOG Practice Bulletin No. 203. American College of Obstetricians and Gynecologists","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R2-20260826","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/AOG.0000000000002357","article-title":"Disparities in chronic conditions among women hospitalized for delivery in the United States, 2005-2014","volume":"130","author":"Admon","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R3-20260826","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(03)13063-2","article-title":"Age-specific relevance of usual blood pressure to vascular mortality","volume":"361","author":"Adab","year":"2003","journal-title":"Lancet"},{"key":"R4-20260826","first-page":"e484","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart association task force on clinical practice guidelines","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"key":"R5-20260826","doi-asserted-by":"crossref","first-page":"g2301","DOI":"10.1136\/bmj.g2301","article-title":"Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis","volume":"348","author":"Bramham","year":"2014","journal-title":"BMJ"},{"key":"R6-20260826","doi-asserted-by":"crossref","first-page":"e018494","DOI":"10.1161\/JAHA.120.018494","article-title":"Impact of chronic hypertension and antihypertensive treatment on adverse perinatal outcomes: systematic review and meta-analysis","volume":"10","author":"Al Khalaf","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R7-20260826","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1161\/HYPERTENSIONAHA.118.11660","article-title":"Estimated impact of the 2017 American College of Cardiology\/American Heart association blood pressure guidelines on reproductive-aged women","volume":"72","author":"Topel","year":"2018","journal-title":"Hypertension"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"e213808","DOI":"10.1001\/jamanetworkopen.2021.3808","article-title":"Prevalence of hypertension among pregnant women when using the 2017 American College of Cardiology\/American Heart association blood pressure guidelines and association with maternal and fetal outcomes","volume":"4","author":"Bello","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R9-20260826","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ajog.2022.10.004","article-title":"American College of Cardiology and American Heart Association blood pressure categories: a systematic review of the relationship with adverse pregnancy outcomes in the first half of pregnancy","volume":"228","author":"Slade","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20260826","doi-asserted-by":"crossref","first-page":"521.e1","DOI":"10.1016\/j.ajog.2020.10.049","article-title":"Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension","volume":"224","author":"Greenberg","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20260826","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1055\/s-0041-1739470","article-title":"Adverse perinatal outcomes associated with stage 1 hypertension in pregnancy: a retrospective cohort study","volume":"40","author":"Norton","year":"2023","journal-title":"Am J Perinatol"},{"key":"R12-20260826","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/ppe.12858","article-title":"Chronic hypertension and risk of preterm delivery: National Longitudinal Study of Adolescents to Adult Health","volume":"36","author":"Delker","year":"2022","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R13-20260826","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejogrb.2023.03.011","article-title":"Is blood pressure 120-139\/80-89 mmHg before 20 weeks a risk factor for hypertensive disorders of pregnancy? A meta-analysis","volume":"284","author":"Sisti","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R14-20260826","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/AOG.0000000000002870","article-title":"Maternal outcomes associated with lower range stage 1 hypertension","volume":"132","author":"Sutton","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R15-20260826","doi-asserted-by":"crossref","first-page":"277.e1","DOI":"10.1016\/j.ajog.2019.06.031","article-title":"Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women","volume":"221","author":"Hauspurg","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20260826","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/HYPERTENSIONAHA.118.11196","article-title":"Aspirin effect on adverse pregnancy outcomes associated with stage 1 hypertension in a high-risk cohort","volume":"72","author":"Hauspurg","year":"2018","journal-title":"Hypertension"},{"key":"R17-20260826","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"key":"R18-20260826","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N Engl J Med"},{"key":"R19-20260826","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/dc18-2021","article-title":"Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): maternal glycemia and childhood glucose metabolism","volume":"42","author":"Scholtens","year":"2019","journal-title":"Diabetes Care"},{"key":"R20-20260826","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jama.2018.11628","article-title":"Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity","volume":"320","author":"Lowe","year":"2018","journal-title":"JAMA"},{"key":"R21-20260826","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0020-7292(02)00092-9","article-title":"The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study","volume":"78","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"R22-20260826","doi-asserted-by":"crossref","first-page":"109790","DOI":"10.1016\/j.diabres.2022.109790","article-title":"Associations of glycemia and lipid levels in pregnancy with dyslipidemia 10-14 years later: the HAPO Follow-Up Study","volume":"185","author":"Lowe","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"R23-20260826","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R24-20260826","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"R26-20260826","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"R27-20260826","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1055\/s-0040-1709465","article-title":"ACC-AHA diagnostic criteria for hypertension in pregnancy identifies patients at intermediate risk of adverse outcomes","volume":"38","author":"Darwin","year":"2021","journal-title":"Am J Perinatol"},{"key":"R28-20260826","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1161\/CIR.0000000000001124","article-title":"Optimizing prepregnancy cardiovascular health to improve outcomes in pregnant and postpartum individuals and offspring: a scientific statement from the American Heart association","volume":"147","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"R29-20260826","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/CIRCRESAHA.123.322762","article-title":"Body mass index, adverse pregnancy outcomes, and cardiovascular disease risk","volume":"133","author":"Khan","year":"2023","journal-title":"Circ Res"},{"key":"R30-20260826","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N Engl J Med"},{"key":"R31-20260826","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","article-title":"Treatment for mild chronic hypertension during pregnancy","volume":"386","author":"Tita","year":"2022","journal-title":"N Engl J Med"},{"key":"R32-20260826","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/AOG.0000000000005410","article-title":"Perinatal outcomes associated with management of stage 1 hypertension","volume":"142","author":"Bailey","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R33-20260826","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/AOG.0000000000004925","article-title":"Progression to severe chronic hypertension 5-7 years after a pregnancy with mild chronic hypertension","volume":"140","author":"Oben","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R34-20260826","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/jamacardio.2021.4391","article-title":"Interventions to mitigate risk of cardiovascular disease after adverse pregnancy outcomes: a review","volume":"7","author":"Jowell","year":"2022","journal-title":"JAMA Cardiol"},{"key":"R35-20260826","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jama.2023.11210","article-title":"Trends in cardiovascular health counseling among postpartum individuals","volume":"330","author":"Cameron","year":"2023","journal-title":"JAMA"},{"key":"R36-20260826","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000508036","article-title":"Hypertensive disorders of pregnancy and risk of cardiovascular disease-related morbidity and mortality: a systematic review and meta-analysis","volume":"145","author":"Wu","year":"2020","journal-title":"Cardiology"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:01:44Z","timestamp":1787742104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005674","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"2024-03-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}